Cargando…

Early changes in 25-hydroxyvitamin D levels and bone markers after monthly risedronate with cholecalciferol in Korean patients with osteoporosis

PURPOSE: This study investigated the efficacy and safety of monthly risedronate, with and without cholecalciferol, on 25-hydroxyvitamin D (25[OH]D) levels and bone markers in Korean patients with osteoporosis. METHODS: A randomized, double-blinded, prospective, 16-week clinical trial was conducted i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Ho Yeon, Koo, Jawon, Kwon, Su Kyoung, Kang, Moo-IL, Moon, Seong-Hwan, Park, Jin-Young, Shin, Chan Soo, Yoon, Byung-Koo, Yoon, Hyun-Koo, Chang, Jae-Suk, Chung, Yoon-Sok, Park, Hyoung-Moo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673862/ https://www.ncbi.nlm.nih.gov/pubmed/23761968 http://dx.doi.org/10.2147/CIA.S44395

Ejemplares similares

Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with Osteoporosis
por: Cho, In-Jin, et al.
Publicado: (2015)

Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
por: Chung, Yoon-Sok, et al.
Publicado: (2009)

An Observational Study to Assess the Safety and Efficacy on Quality of Life and Patient Satisfaction With Raloxifene/Cholecalciferol Combination Therapy in Postmenopausal Women Requiring Prevention or Treatment for Osteoporosis
por: Chung, Yoon-Sok, et al.
Publicado: (2021)

Kinetics of serum 25-hydroxyvitamin D in haemodialysis patients treated with monthly oral cholecalciferol
por: Jean, Guillaume, et al.
Publicado: (2015)

Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis
por: Chung, Yoon-Sok, et al.
Publicado: (2016)

Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial
por: Yoon, Byung-Koo, et al.
Publicado: (2017)

Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women
por: Lee, Dong-Yun, et al.
Publicado: (2022)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
por: Cho, Yong Ho, et al.
Publicado: (2020)

Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
por: Koh, Jung-Min, et al.
Publicado: (2016)

Persistent Increase in Serum 25-Hydroxyvitamin D Concentration in a Dog Following Cholecalciferol Intoxication
por: Gerhard, Charlotte, et al.
Publicado: (2020)

The serum level of 25-hydroxyvitamin D for maximal suppression of parathyroid hormone in children: the relationship between 25-hydroxyvitamin D and parathyroid hormone
por: Kang, Jung In, et al.
Publicado: (2017)

Serum 25-hydroxyvitamin D and Metabolic Parameters in Healthy Korean Adults: Korean National Health and Nutrition Examination Survey VI
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density
por: Koo, Young-Ah, et al.
Publicado: (2019)

Epidemiology of Osteoporosis and Osteoporotic Fractures in South Korea
por: Lee, Young-Kyun, et al.
Publicado: (2013)

Gender difference in relationship between serum ferritin and 25-hydroxyvitamin D in Korean adults
por: Seong, Jeong Min, et al.
Publicado: (2017)

GnRH Agonist Therapy to Protect Ovarian Function in Young Korean Breast Cancer Patients
por: Park, Hyun Jung, et al.
Publicado: (2010)

Simple Fast Quantification of Cholecalciferol, 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D in Adipose Tissue Using LC-HRMS/MS
por: Bonnet, Laurianne, et al.
Publicado: (2019)

Medical treatment of severe osteoporosis including new concept of advanced severe osteoporosis
por: Choi, Han Seok, et al.
Publicado: (2016)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
por: Bobba, Raja, et al.
Publicado: (2007)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
por: Moro-Álvarez, María J, et al.
Publicado: (2008)

The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
por: Park, Jee Soo, et al.
Publicado: (2019)

Low serum 25-hydroxyvitamin D levels, tooth loss, and the prevalence of severe periodontitis in Koreans aged 50 years and older
por: Kim, Hyunju, et al.
Publicado: (2020)

The effect of proto-type wearable light-emitting devices on serum 25-hydroxyvitamin D levels in healthy adults: a 4-week randomized controlled trial
por: Lee, Hyuk Joo, et al.
Publicado: (2022)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Rackoff, Paula
Publicado: (2009)

The efficacy of denosumab in Korean male patients with osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2022)

Basal Vitamin D Status and Supplement Dose Are Primary Contributors to Maternal 25-Hydroxyvitamin D Response to Prenatal and Postpartum Cholecalciferol Supplementation
por: Levy, Benjamin, et al.
Publicado: (2021)

Knowledge on Osteoporosis of Prescriber According to Level of Medical Institute
por: Yoon, Byung-Ho, et al.
Publicado: (2014)

Serum 25-Hydroxyvitamin D Concentration Is Independently Inversely Associated with Insulin Resistance in the Healthy, Non-Obese Korean Population
por: Ock, So Young, et al.
Publicado: (2016)

Relationship between homeostasis model assessment of insulin resistance and beta cell function and serum 25-hydroxyvitamin D in non-diabetic Korean adults
por: Yoon, Hyun, et al.
Publicado: (2016)

Current Status of Sarcopenia in Korea: A Focus on Korean Geripausal Women
por: Park, Hyoung Moo
Publicado: (2018)

A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data
por: McClung, Michael R., et al.
Publicado: (2012)

Association between pterygium, sun exposure, and serum 25-hydroxyvitamin in a nationally representative sample of Korean adults
por: Chun, Yoon Hong, et al.
Publicado: (2018)

Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
por: Gates, Brian J., et al.
Publicado: (2012)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Masud, Tahir, et al.
Publicado: (2009)

The association between serum ferritin and 25-hydroxyvitamin D and metabolic syndrome in Korean women: the Korea National Health and Nutrition Examination Survey 2010–2012
por: Yoon, Hyun, et al.
Publicado: (2017)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
por: Smelt, Hendrika J.M., et al.
Publicado: (2019)

Association between serum 25-hydroxyvitamin D levels and myopia in general Korean adults
por: Jung, Byung J, et al.
Publicado: (2020)

Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry
por: Yoon, Hyun Koo, et al.
Publicado: (2017)

Prevalence of Sarcopenia in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys
por: Kwon, Hyoung-Joon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cdme416nse8lgo11a3aeunketa